Literature DB >> 3490475

"Glycated" osteocalcin in human and bovine bone. The effect of age.

C M Gundberg, M Anderson, I Dickson, P M Gallop.   

Abstract

Purified osteocalcin from cow and calf bone was analyzed for nonenzymatic glycosylation (glycation) by sodium [3H]borohydride reduction. Calf bone was found to be approximately 5% glycated, while bone from mature cows was 10% glycated. These results were confirmed by a second method which utilizes periodate oxidation followed by formaldehyde fluorescence. Osteocalcin in human bone was also found to be glycated. The content of glycated osteocalcin from the bones of 47 nondiabetic individuals, aged 0.6-97, was dependent upon age. The extent of glycation was lowest in children, was constant through the adult years, and increased linearly in bone taken from individuals aged 60-97. Glycated osteocalcin was purified by boronate affinity chromatography and subjected to one-step Edman degradation. It was established that the site of glycation was the amino-terminal tyrosine. Increases in the amount of glycated osteocalcin in the bones of older individuals may play a role in the pathogenesis of senile osteoporosis and in the osteopenia which may accompany diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3490475

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Biochemical characterization of major bone-matrix proteins using nanoscale-size bone samples and proteomics methodology.

Authors:  Grazyna E Sroga; Lamya Karim; Wilfredo Colón; Deepak Vashishth
Journal:  Mol Cell Proteomics       Date:  2011-05-23       Impact factor: 5.911

2.  Influence of carboxylation on osteocalcin detection by mass spectrometry.

Authors:  Timothy P Cleland; Corinne J Thomas; Caren M Gundberg; Deepak Vashishth
Journal:  Rapid Commun Mass Spectrom       Date:  2016-10-15       Impact factor: 2.419

3.  Advanced Glycation End-products and Bone Fractures.

Authors:  Deepak Vashishth
Journal:  IBMS Bonekey       Date:  2009-08

4.  Bisphosphonate-associated femoral fracture: implications for management in patients with malignancies.

Authors:  N Napoli; D Novack; R Armamento-Villareal
Journal:  Osteoporos Int       Date:  2009-08-11       Impact factor: 4.507

5.  Suggestion of a deficient osteoblastic function in diabetes mellitus: the possible cause of osteopenia in diabetics.

Authors:  H Rico; E R Hernandez; J A Cabranes; F Gomez-Castresana
Journal:  Calcif Tissue Int       Date:  1989-08       Impact factor: 4.333

6.  Identification of glycation at the N-terminus of albumin by gas chromatography-mass spectrometry.

Authors:  D A Robb; O S Olufemi; D A Williams; J M Midgley
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

7.  Glycation of the human erythrocyte glucose transporter in vitro and its functional consequences.

Authors:  P J Bilan; A Klip
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

Review 8.  Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties.

Authors:  Lamya Karim; Mary L Bouxsein
Journal:  Bone       Date:  2015-07-23       Impact factor: 4.398

9.  Expression of collagen, osteocalcin, and bone alkaline phosphatase in a mineralizing rat osteoblastic cell culture.

Authors:  P Collin; J R Nefussi; A Wetterwald; V Nicolas; M L Boy-Lefevre; H Fleisch; N Forest
Journal:  Calcif Tissue Int       Date:  1992-02       Impact factor: 4.333

10.  Glycation (non-enzymic glycosylation) inactivates glutathione reductase.

Authors:  R Blakytny; J J Harding
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.